comparemela.com
Home
Live Updates
Dr Eng on the Ongoing Investigation of Fruquintinib in Relapsed/Refractory mCRC : comparemela.com
Dr Eng on the Ongoing Investigation of Fruquintinib in Relapsed/Refractory mCRC
Cathy Eng, MD, FACP, FASCO, discusses the ongoing investigation of fruquintinib in patients with relapsed/refractory metastatic colorectal cancer.
Related Keywords
Davidh Johnson ,
Cathy Eng ,
Gastrointestinal Gi Cancer Research Program ,
Vanderbilt Ingram Cancer Center ,
Swog Gi Committee ,
Vanderbilt Ingram Cancer Center Young Adult Cancers Initiative ,
Medical Oncology ,
Cancer Research Program ,
Clinical Updates In Colorectal Cancer ,
Onclive Tv ,
Metastatic Colorectal Cancer ,
comparemela.com © 2020. All Rights Reserved.